November 10, 2026 · Journal of cardiac failure · DOI: 10.1016/j.cardfail.2026.08.035

Artificial Intelligence‒Guided Phenotyping of Cardiomyopathies: From Detection to Surveillance.

Listen to this summary

This review examines how artificial intelligence can improve the diagnosis, phenotyping, risk stratification, and monitoring of cardiomyopathies, using hypertrophic cardiomyopathy (HCM) and transthyretin amyloid cardiomyopathy (ATTR-CM) as primary examples. The authors ask whether AI applied to multimodal data (history, ECG, imaging, biomarkers, and health records) can detect underdiagnosed disease, quantify its severity, and predict its course. They also propose a forward-looking framework for AI-guided phenotyping that addresses label quality, generalizability, false positives in low-prevalence settings, regulation, and the need for prospective evidence that human-AI collaboration improves patient outcomes.

Evangelos K Oikonomou, Rohan Khera, Ahmad Masri

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play